Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004090746 | SCV003554648 | uncertain significance | not specified | 2022-08-08 | criteria provided, single submitter | clinical testing | The c.502C>T (p.H168Y) alteration is located in exon 1 (coding exon 1) of the OR51B5 gene. This alteration results from a C to T substitution at nucleotide position 502, causing the histidine (H) at amino acid position 168 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |